JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, Z.-y.
Right arrow Articles by Xia, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, Z.-y.
Right arrow Articles by Xia, Z.
Related Collections
Right arrow Myocardial protection

J Thorac Cardiovasc Surg 2005;130:258-264
© 2005 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease

Zhong-yuan Xia, MD a , b , Xian-Yi Liu, MD a , b , Li-ying Zhan, MD a , b , Yi-hong He, BSc a , Tao Luo, MD a , b , Zhengyuan Xia, MD, PhD a , b , *

a Anesthesiology Research Laboratory, Renmin Hospital, Wuhan University, Wuhan, People’s Republic of China
b Department of Anesthesiology, Renmin Hospital, Wuhan University, Wuhan, People’s Republic of China

Presented in part at the First Global Conference on Cardiovascular Clinical Trials and Pharmacotherapy incorporating the Second World Heart Federation Global Conference on Cardiovascular Clinical Trials and Thirteenth International Society of Cardiovascular Pharmacotherapy Congress, Oct 1–3, 2004.

Received for publication November 21, 2004; revisions received January 26, 2005; accepted for publication February 7, 2005.

* Address for reprints: Zhengyuan Xia, MD, Anesthesiology Research Laboratory, Department of Anesthesiology, Renmin Hospital, Wuhan University, Wuhan, 430060, People’s Republic of China, or Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 E Mall, Vancouver, BC, V6T 1Z3 Canada (Email: zhengyuan_xia{at}yahoo.com).

OBJECTIVE: This study was undertaken to demonstrate that gastrointestinal mucosal injury occurs during cardiopulmonary bypass in children, increasing systemic inflammatory responses, and to determine whether shen-fu injection (the major components of which are ginsenosides compound, extract of Panax ginseng shown to have antioxidant properties) could attenuate gastrointestinal mucosal injury and subsequent inflammatory responses.

METHODS: Twenty-four children undergoing heart surgery for congenital heart defects were randomly assigned to groups C (placebo control, n = 12) and G (1.35 mg/kg ginsenosides compound intravenously before and throughout the course of cardiopulmonary bypass, n = 12). Central venous blood samples were taken before cardiopulmonary bypass and at 60 and 120 minutes after aortic declamping (reperfusion). Gastric intramucosal pH was measured by perioperative tonometry. Plasma lipid peroxidation product malondialdehyde, myocardium-specific creatine kinase isoenzyme MB activity, diamine oxidase, lipopolysaccharide, and interleukin 6 were all measured.

RESULTS: Significant decrease in gastric intramucosal pH and increase in plasma diamine oxidase were seen during reperfusion in group C, accompanied by increases in plasma levels of malondialdehyde, lipopolysaccharide, interleukin 6, and creatine kinase isoenzyme MB (P < .01 vs before cardiopulmonary bypass). Shen-fu injection significantly attenuated these changes (P < .05). Consequently, fewer patients in group G (2/12) than in group C (7/12) needed postoperative inotropic support. Postoperative intensive care unit stay was shorter in group G than in group C. A tight positive correlation was seen between diamine oxidase and interleukin 6 at 60 minutes after aortic declamping and between diamine oxidase and lipopolysaccharide at 120 minutes after aortic declamping (r = 0.79, P < .0001).

CONCLUSION: Ginsenosides compound may attenuate gastrointestinal injury and inhibit inflammatory response after cardiopulmonary bypass in patients with congenital heart disease.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
Z. Xia, Z. Huang, and D. M. Ansley
Large-Dose Propofol During Cardiopulmonary Bypass Decreases Biochemical Markers of Myocardial Injury in Coronary Surgery Patients: A Comparison with Isoflurane.
Anesth. Analg., September 1, 2006; 103(3): 527 - 532.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.